TransMedics Appoints New CFO Fernando Araujo, Reaffirms 2026 Revenue Guidance

TransMedics announced the appointment of Fernando Araujo as its new Chief Financial Officer and Treasurer, effective September 21, 2026. Mr. Araujo, previously an executive at GE HealthCare and 3M, succeeds Gerardo Hernandez. Concurrently, the company reiterated its full-year 2026 revenue guidance.

Key Details

• New CFO: Fernando Araujo will receive an annual base salary of $590,000, a target bonus of 60%, a $200,000 sign-on bonus, and initial equity awards valued at approximately $3.5 million.
• Leadership Transition: Outgoing CFO Gerardo Hernandez will transition to a new role as a senior advisor to lead the company's expansion into Latin America, remaining with the company until April 30, 2027.
• Financial Outlook: TransMedics reaffirmed its full-year 2026 revenue guidance of $737 million to $757 million, representing 22% to 25% year-over-year growth.